A Rare Case of Pembrolizumab Associated Encephalopathy

Authors

Sijan Basnet, Department of Medicine, Reading HospitalFollow
Rajanbir Singh, Xavier University School of Medicine
Biswaraj Tharu, Mayo Clinic
Tushar Pawar, Willis-Knighton Medical Center
Garima Basnet, KIST Medical College

Abstract

We present a unique case of a 55-year-old man with confusion thought to be due to pembrolizumab which he was receiving for renal cell carcinoma. His workup for other possible etiologies for encephalopathy was negative. He was treated with high dose intravenous methylprednisolone followed by prednisone taper and intravenous immunoglobulin with gradual improvement in his mentation.

Recommended Citation

Basnet, Sijan; Singh, Rajanbir; Tharu, Biswaraj; Pawar, Tushar; and Basnet, Garima (2022) "A Rare Case of Pembrolizumab Associated Encephalopathy," Journal of Community Hospital Internal Medicine Perspectives: Vol. 12: Iss. 5, Article 10.
DOI: 10.55729/2000-9666.1091
Available at: https://scholarlycommons.gbmc.org/jchimp/vol12/iss5/10